Print the pageECVAM News & Views
REACH Implementation Project RIP 3.3
Kick-off Meeting of the COMICS FP6 STREP Project
ECVAM Validation Management Group Meeting on the Retrospective Validation of Cell Cytotoxicity and Cell Function-based Assays for Eye Irritation
Meeting on Standardisation of Cell Culture Procedures for Growth and Differentiation of Human Embryonic Stem Cell Lines for Toxicity Testing
Colipa Skin Tolerance Task Force Meeting
ECVAM Skin Irritation Validation Study (SIVS)
Finalisation of the Interim Report of the ReProTect Integrated Project Joint Meeting of the ECVAM Study “Evaluation of the Performance of Five Selected In Vitro Blood–Brain Barrier Models for Predicting Absorption/Uptake into the Brain”
Management Board Meeting of the ACuteTox Project
Visit of Students from the European Master in Risk Assessment and Risk Analysis Course
Simposio Italiano di Nanotossicologia
5th Meeting of the ECVAM Steering Group on Biologicals
Key Publications
STATEMENT ON THE APPLICATION OF THE CFU–GM ASSAY FOR PREDICTING ACUTE NEUTROPENIA IN HUMANS
STATEMENT ON THE VALIDITY OF IN VITRO PYROGEN TESTS
STATEMENT ON THE SCIENTIFIC VALIDITY OF THE UPPER THRESHOLD CONCENTRATION (UTC) STEP-DOWN APPROACH — A NEW TESTING STRATEGY TO REDUCE THE USE OF FISH IN ACUTE AQUATIC TOXICITY TESTING
STATEMENT ON DOG TOXICITY STUDIES
STATEMENT ON DIRECTIVE 86/609/EEC ARTICLE 23 ON OPPORTUNITIES FOR TRAINING AND DEVELOPMENT OF SCIENCE IN VALIDATION OF THE 3RS
STATEMENT ON THE SCIENTIFIC VALIDITY OF THE IN VITRO MICRONUCLEUS TEST AS AN ALTERNATIVE TO THE IN VITRO CHROMOSOME ABERRATION ASSAY FOR GENOTOXICITY TESTING
STATEMENT ON THE APPLICATION OF THE SKINETHIC™ HUMAN SKIN MODEL FOR SKIN CORROSIVITY TESTING